58 related articles for article (PubMed ID: 21067358)
1. Probe detects HIV protease and toxicity of drugs.
AIDS Patient Care STDS; 2010 Nov; 24(11):744. PubMed ID: 21067358
[No Abstract] [Full Text] [Related]
2. Quantitative assessment of in vivo HIV protease activity using genetically engineered QD-based FRET probes.
Cella LN; Biswas P; Yates MV; Mulchandani A; Chen W
Biotechnol Bioeng; 2014 Jun; 111(6):1082-7. PubMed ID: 24473897
[TBL] [Abstract][Full Text] [Related]
3. Visualization of human immunodeficiency virus protease inhibition using a novel Förster resonance energy transfer molecular probe.
Jin S; Ellis E; Veetil JV; Yao H; Ye K
Biotechnol Prog; 2011 Jul; 27(4):1107-14. PubMed ID: 21584951
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of probe signal for screening of HIV-1 protease inhibitors in living cells.
Yao H; Jin S
Sensors (Basel); 2012 Dec; 12(12):16759-70. PubMed ID: 23223077
[TBL] [Abstract][Full Text] [Related]
5. Fluorogenic assay and live cell imaging of HIV-1 protease activity using acid-stable quantum dot-peptide complex.
Choi Y; Lee J; Kim K; Kim H; Sommer P; Song R
Chem Commun (Camb); 2010 Dec; 46(48):9146-8. PubMed ID: 21049123
[TBL] [Abstract][Full Text] [Related]
6. Sidechain-linked inhibitors of HIV-1 protease dimerization.
Bowman MJ; Chmielewski J
Bioorg Med Chem; 2009 Feb; 17(3):967-76. PubMed ID: 18337105
[TBL] [Abstract][Full Text] [Related]
7. A quantum-dot based protein module for in vivo monitoring of protease activity through fluorescence resonance energy transfer.
Biswas P; Cella LN; Kang SH; Mulchandani A; Yates MV; Chen W
Chem Commun (Camb); 2011 May; 47(18):5259-61. PubMed ID: 21445447
[TBL] [Abstract][Full Text] [Related]
8. Metabolic abnormalities and use of HIV-1 protease inhibitors.
Martinez E; Gatell J
Lancet; 1998 Sep; 352(9130):821-2. PubMed ID: 9737319
[No Abstract] [Full Text] [Related]
9. Crucial amides for dimerization inhibitors of HIV-1 protease.
Bowman MJ; Chmielewski J
Bioorg Med Chem Lett; 2004 Mar; 14(6):1395-8. PubMed ID: 15006369
[TBL] [Abstract][Full Text] [Related]
10. Novel nonpeptidic inhibitors of HIV-1 protease obtained via a new multicomponent chemistry strategy.
Yehia NA; Antuch W; Beck B; Hess S; Schauer-Vukasinović V; Almstetter M; Furer P; Herdtweck E; Dömling A
Bioorg Med Chem Lett; 2004 Jun; 14(12):3121-5. PubMed ID: 15149657
[TBL] [Abstract][Full Text] [Related]
11. Dimerization inhibitors of HIV-1 protease.
Boggetto N; Reboud-Ravaux M
Biol Chem; 2002 Sep; 383(9):1321-4. PubMed ID: 12437124
[TBL] [Abstract][Full Text] [Related]
12. Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants.
Majerová-Uhlíková T; Dantuma NP; Lindsten K; Masucci MG; Konvalinka J
J Clin Virol; 2006 May; 36(1):50-9. PubMed ID: 16527535
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel HIV-1 protease inhibitors using tertiary amine as P2-ligands.
Yang ZH; Bai XG; Zhou L; Wang JX; Liu HT; Wang YC
Bioorg Med Chem Lett; 2015 May; 25(9):1880-3. PubMed ID: 25838144
[TBL] [Abstract][Full Text] [Related]
14. [HIV-1 protease inhibitors: cell metabolism and drug resistance (review)].
Bobkova MR
Ter Arkh; 2008; 80(10):77-80. PubMed ID: 19105421
[No Abstract] [Full Text] [Related]
15. Novel insight into inhibitor binding of highly symmetric HIV-1 protease.
Wollmann J; Baumert C; Erlenkamp G; Sippl W; Hilgeroth A
Chembiochem; 2008 Apr; 9(6):874-8. PubMed ID: 18318035
[No Abstract] [Full Text] [Related]
16. A mechanistic study of 3-aminoindazole cyclic urea HIV-1 protease inhibitors using comparative QSAR.
Garg R; Bhhatarai B
Bioorg Med Chem; 2004 Nov; 12(22):5819-31. PubMed ID: 15498658
[TBL] [Abstract][Full Text] [Related]
17. Importance of polar solvation and configurational entropy for design of antiretroviral drugs targeting HIV-1 protease.
Kar P; Lipowsky R; Knecht V
J Phys Chem B; 2013 May; 117(19):5793-805. PubMed ID: 23614718
[TBL] [Abstract][Full Text] [Related]
18. A combined QM/MM approach to protein--ligand interactions: polarization effects of the HIV-1 protease on selected high affinity inhibitors.
Hensen C; Hermann JC; Nam K; Ma S; Gao J; Höltje HD
J Med Chem; 2004 Dec; 47(27):6673-80. PubMed ID: 15615516
[TBL] [Abstract][Full Text] [Related]
19. Structure-based inhibitors of HIV-1 protease.
Wlodawer A; Erickson JW
Annu Rev Biochem; 1993; 62():543-85. PubMed ID: 8352596
[No Abstract] [Full Text] [Related]
20. First bioanalytical evaluation of nonpeptidic cage dimeric HIV-1 protease inhibitor N-benzyl 4-aryl-1,4-dihydropyridine H17: biotransformation and toxicity on Hep G2 cells.
Hilgeroth A; Langner A
Arch Pharm (Weinheim); 2000 Jan; 333(1):32-4. PubMed ID: 10675987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
